An innovative therapy program for people who want to reduce their methamphetamine use will be trialled in a new study from the National Centre for Clinical Research on Emerging Drugs (NCCRED).
Recruitment is currently underway for the IMPACT study, which will offer internet-based cognitive behavioural therapy (iCBT) for people who use methamphetamine.
NCCRED Knowledge Translation Lead Dora Karavasilis said the six-week program was designed to teach practical skills for people to manage their cravings and reduce their methamphetamine use.
“We know traditional face-to-face CBT can help reduce substance use, cravings and relapse for some substance use disorders, including alcohol, cannabis and methamphetamine, but access remains a major issue,” Ms Karavasilis said.
NCCRED Senior Research Associate, Dr Kathryn Fletcher, Chief Investigator on the Project said internet-based CBT was a viable alternative to in-person therapy.
“It’s more accessible and flexible for those seeking support, but we still need more evidence to support its use for treating addiction
“Our study will look at whether this is a safe and feasible option to help people reduce their methamphetamine use, and if we could look to roll this out on a larger scale.”
The research team will recruit up to 70 adults who use methamphetamine to complete six weekly online lessons, with short daily activities and the flexibility to move through the content at their own pace.
At the end of the six weeks, participants will be invited to complete a follow-up survey about their satisfaction with the program and any changes in their methamphetamine use.
“While iCBT is generally considered safe, some participants may experience discomfort or distress when answering questions about their substance use, and some of the content may be emotionally challenging or triggering,” Dr Fletcher said.
“We will encourage participants to take breaks as needed, seek additional support or treatment, or withdraw from the study altogether, as their emotional wellbeing is crucial.”
Recruitment is currently underway, with study completion expected around December 2027.
Background
Australia has the highest estimated prevalence of methamphetamine dependence globally, and recent wastewater analyses have shown increased use across all states and territories.
Over the past decade, methamphetamine has become the most common illicit drug for which people seek treatment, but access to evidence-based treatment remains an issue.
On average, people delay seeking help for 5-10 years after experiencing harms, and access is gendered with fewer women seeking treatment than men despite similar rates of use.
